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1. Introduction 
Many of the motile processes performed by euca- 
ryotic cells have been attributed to the functional 
properties of the actin-based microfilament system 
[l-3]. In addition to the presence of actin in micro- 
filaments, this protein is also found as unpolymerized 
monomers in homogenates of various tissues and cells 
[3]. Monomeric actin can be isolated from a variety 
of sources in a 1: 1 complex with profilin, a small 
basic protein affecting the polymerizability of actin 
[4-71. 
A rapid biochemical assay for the quantification of 
actin has been described [8] which can discriminate 
unpolymerized and filamentous actin in mixtures of 
purified components and cell homogenates. Using this 
technique, it was shown that the thrombin-induced 
transformation of human platelets from smooth discs 
to spiky spheres, is concomitant with a reorganization 
of actin from an unpolymerized to a filamentous 
form [9,10]. 
The motile behaviour of insulin secreting p-cells 
from the pancreas is similar in several respects to that 
observed with other cells [ 1 l-181. The P-cells have 
also been shown to contain actin [ 191 and myosin 
[20], and insulin-storage granules interact in vitro with 
purified fdamentous actin [21]. 
Here we present evidence to support the idea that 
microfilaments are directly involved in the secretion 
of insulin since exposure of the p-cells to glucose, the 
major physiological stimulator, was accompanied by 
an increase in the fraction of filamentous actin. 
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2. Materials and methods 
Adult ob/ob mice taken from a local non-inbred 
colony were used as the source of pancreatic islets 
containing >90% &cells [22]. In each experiment, 
the pancreatic glands were removed from 4 animals 
starved overnight. Each pancreas was cut into pieces 
and placed in 2 ml incubation medium supple- 
mented with 3 mg collagenase (type IV, 170 U/mg, 
Worthington Biochemical Corp., Freehold, NJ, 
EC 3.4.24.3). The basal solution used for isolation 
and incubation of the islets was a modified Krebs- 
Ringer medium containing 1 mM glucose, 1 mg/ml 
bovine serum albumin and 2.56 mM CaCl*, with 
phosphate and sulphate replaced by equimolar 
amounts of chloride, and the buffering capacity 
(pH 7.4) provided by 25 mM Hepes instead of bicar- 
bonate [23]. After vigorous shaking for 18 min at 
37”C, the digests were rinsed several times with incu- 
bation medium after which -600 islets were selected 
under a stereo microscope. 
The islets were pre-incubated in 6 ml incubation 
medium containing 1 mM glucose for 45 min with 
shaking at 37°C. At the end of this period, the islets 
were transferred to 6 ml fresh test medium containing 
either 1 mM or 20 mM glucose. After a further 
60 min incubation, samples of the medium were 
taken for the measurement of insulin [24]. The islets 
were subsequently lysed and homogenized at 4°C in 
50 /.d 10 mM potassium phosphate buffer (pH 7.6) 
supplemented with 150 mM NaCl, 2 mM MgClz, 
0.2 mM ATP, 0.2 mM dithioerythritol, 0.01 mM 
phenylmethylsulfonylfluoride and 0.5% Triton 
X-100. Samples of the lysed islets were retained for 
measurement of protein content [25 1. 
Aliquots of the islet homogenates were taken for 
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the determination of unpolymerized and total actin 
by the DNase 1 inhibition assay [8]. The DNase 1 
(DN-100, Sigma) batch used in these experiments 
was calibrated with known amounts of purified 
spleen profilactin [4]. Only 3.3 3 DNase stock solu- 
tion (0.27 ,ug) was used in the assay together with 
1 ml of the DNA substrate [8]. This modification in 
the assay procedure was introduced because the 
number of intact islets that could be obtained in each 
experiment was limited to -600. For determination 
of inhibitor activity the DNase was mixed with 
l-5 ~1 samples of the islet homogenate o inhibit 
the DNase activity to -50%. In the determination 
of the total actin content, 10 fi of the homogenate 
was diluted with 40 ti lysis buffer to decrease the 
viscosity of the sample once it had been mixed at 4*C 
with 50 fl of the guanidine-HCl solution described 
in [8]. Of this mixture lo-20 ~1 samples were taken 
to the DNase inhibition assay. 
The concentration of purified proteins was deter- 
mined spectrophotometrically, using the following 
values for I$&: DNase 1 = 12.3 [26], and profil- 
actin = 10.4 [4]. 
3. Results 
One unit of in~bitor activity is defined as the 
amount of actin which gives 1% inhibition of the 
standard amount of DNase 1 (in this case 0.27 vg), 
and the batch of DNase used in these experiments 
was calibrated with known concentrations of purified 
prof;iactin (fig.1). Under these conditions, an inbibi- 
Actin concentmtlon (pg/ml) 
Fig.1. Standard curve for the estimation of actin using the 
DNase inhibition assay. Profilactin from calf spleen was pre- 
pared as in [lo], and dissolved in 10 mM potassium phos- 
phate buffer (pH 7.6), 150 mM NaCl, 2 mM MgCl,, 0.2 mM 
ATP, 0.2 mM dithioery~ritol and 0.5% Triton X-100. DNase 
~hibitor activity was measured as in section 2, both before 
(0) and after (0) treatment with ~~id~e-H~ over the 
range of actin concentrations indicated. All measurements 
were made with the same batch of DNase. 
tor activity of 10 000 units/ml corresponds to 
-40 pg/ml actin. With the miniaturization of the 
assay, the highest concentration of actin that could 
Table 1 
Determination of actin pools and insulin release 
Glucose Unpolymerized Insulin Unpolymerized actin in homogenates Total actin 
(mM) actin as % total release 
actin (figimg 2 min after lysis 60 min after lysis (fig/ml) Wmg 
protein) (f&ml) (pglmg protein) (icglml) (rglmg protein) protein) 
1 81.7 i: 2.8 2.2 f 0.2 88 ?Z 12 5.8 f 0.4 37 f 3 3.0 f 0.2 127 f 15 7.3 f 0.7 
(n =5) (n = 11) (n = 9) (n = 9) (n = 8) (n = 8) (n = 9) (n = 9) 
20 68.8 + 2.9a 4.2 f 0.7b 94*13 6.0 f 0.8 39 f 5 2.5 f 0.3 152 f 22 8.7 1 1.3 
(n = 7) (n = 9) (n = 10) (n = 9) (n = 8) (n = 7) (n = 8) (n = 8) 
ap <o.02;bp <o.oos 
After pre-incubation for 45 min in medium containing 1 mM glucose, 600 islets were transferred to 6 ml medium containing 
either 1 or 20 mM glucose and incubated for 60 min, before insulin and actin pool measurements. The results represent mean 
values f SEM for the no. expt given in parenthesis. Statistical s~i~c~ces were calculated by Student’s f-test 
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Fig.2. Determination of actin pools in homogenates of pan- 
creatic pceiis before and after glucose stimulation. Islets were 
incubated for 60 mm in the presence of either 1 mM or 
20 mM glucose. Thereafter the ceiis were lysed as in section 2 
and DNase inhibitor activity in the homogenates were deter- 
mined at different times after lyais (0). At times indicated by 
the arrows, an aiiquot of the homogenate was diluted with 
lyais buffer and treated with guanidine-HCI before the total 
amount of actin was determined (0). The results were 
expressed as pg actin/ml, calculated from the curve in fig.1. 
be accurately measured was 250 pg/ml. This restric- 
tion is probably due to difficulties in adequate mixing 
of such small sample volumes. In all experiments the 
results are expressed as pg actin calculated from the 
curve in fig.1. 
Analyses of the stability of actin pools in several 
types of cell homogenates have revealed that rapid 
changes in the polymerization state of actin occur 
after cell lysis [8,10]. It is therefore necessary to 
measure the actin pool sizes consecutively in each 
experiment. The results presented in fig.2 illustrate 
such measurements using pancreatic D-cell homoge- 
nates prepared from islets pre-incubated in medium 
containing either low (1 mM) or high (20 mM) glu- 
cose. In these particular experiments, the unpoly- 
merized actin present l-2 min after lysis represented 
-77% of the total actin when the islets had been 
incubated at the low glucose concentration, and 54% 
when incubated at the high concentration of the 
sugar (fig.2). In expressing the unpolymerized actin 
as percentage of the total actin it became clear in a 
series of repeated experiments, that exposure of the 
islets to glucose was associated with a significant 
reduction in the proportion of unpolymerized actin 
(table 1). Accordingly, glucose stimulation of insulin 
secretion was associated with an -2-fold increase in 
the pool of filamentous actin. 
A considerable decrease in the pool of unpoly- 
merized actin was observed during 30-50 min 
incubation at 4°C. After 1 h incubation, the con- 
centration of unpolymerized actin had dropped to 
a constant level which corresponded to a mean of 
-40 pg/ml actin (table 1). This final concentration 
was obtained irrespective of the total concentration 
of actin in the homogenates which ranged from 
50-200 E.cg/ml. 
The total amount of actin can be determined after 
treatment of the homogenates with guanidine-HCl at 
a concentration known to depolymerize tilamentous 
actin [8]. In these homogenates, the release (depoly 
merization) of actin in the presence of guanidine-HCl 
takes up to 15 min to reach a plateau value (fig.2). As 
can be seen in table 1, the total actin concentration 
varied extensively between different preparations of 
islets, but nevertheless represented 0.7-0.9% of the 
islet protein irrespective of the glucose concentration 
during the incubation. 
4. Discussion 
The pancreatic P-cell responds rapidly and with 
great sensitivity by secreting insulin when exposed 
to glucose. The recognition of the secretagogic signal 
is believed to be followed by the accumulation of 
Ca*+ in the submembrane space and the subsequent 
triggering of exocytosis [27]. These data indicate 
that the pool of filamentous actin in &cells increases 
after glucose stimulation of insulin release. Glucose 
control of o-granule discharge might therefore not 
only follow from Ca*+ regulation of the interaction 
between actin and myosin [28,29], but also from an 
increase in the polymerization of actin. The 1 h incu- 
bation of the islets in the presence of glucose may 
not reveal maximal changes in the actin pools. It is 
possible that the early phase of insulin release, which 
occurs at 5-10 min, is associated with an extensive 
polymerization of actin, while late phase is accom- 
panied by stimulation of the synthesis of actin, pre- 
dominantly the monomeric form. Whether a transient 
decrease in the fraction of unpolymerized actin exists 
or not will have to await further experimentation. 
However, in accordance with our results, the number 
of microvilli on the surface of @ells in [30] were 
doubled after exposure to glucose. 
The actin pools in homogenates of &cells exhib- 
ited two unusual features. 
(1) The pool of unpolymerized actin decreased to a 
level comparable to the critical concentration 
needed for filament formation with purified 
actin [31,32]. 
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(2) The release of inhibitor activity in the presence 
of guanidine-HCI was -1 O-times slower than 
that of purified fiamentous actin [8,10]. 
When taken together with [S,lO], this study indicates 
that a subtle balance between polymerizing and fila- 
ment stabilizing activities on one hand and depoly- 
merizing activities on the other hand, determine the 
stability of actin pools in cell lysates. 
These observations show that a marked increase in 
the proportion of filamentous actin accompanies the 
glucose stimulation of insulin secretion. This suggests 
that microfilaments play an active role in the final 
stages of the secretory process. During the course of 
this work a short report was presented [33] where 
that the filamentous actin pool in pancreatic P-cells 
is proposed to be increased after glucose stimulation. 
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